Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Invention for Innovation - Challenge Awards Committee


08 July 2019


2.0 - January 2022


The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: two for Product Development Awards (committee A and committee B), one for Challenge Awards, and one for Connect.

Committee members - Challenge Awards

Professor Nick Lemoine (Chair) Director Barts Cancer Institute Professor Lemoine is the Director of Barts Cancer Institute. His groups' primary research interests are in the genomics and molecular pathology of pancreatic cancer and the development of oncolytic virotherapy.
Ms Jo Smart (Deputy Chair) Chief Operating Officer  VivoPlex Medical Ltd Ms Smart is a life sciences business executive with over 15 years' experience, and is COO of Vivoplex Medical Ltd, a UK medtech SME.
Mrs Janet Champion Public Committee Member   PPI  Representative PPI  Representative
Mr Chris Chaney Chief Executive  Chelsea and Westminster Hospitals NHS Foundation Trust  Mr Chaney leads the innovation programme at Chelsea and Westminster Hospital Foundation Trust, is a member of the Trust Board and CEO of Trust charity, CW+
Dr Iain Hennessey Clinical Director of Innovation Alder Hay Children’s NHS Foundation Trust Dr Hennessey is involved in paediatric surgery, surgical simulation and clinical innovation. 
Professor Claire Hulme Professor of Health Economics Institute of Health Research, University of Exeter Professor Hulme is a health economist whose background lies in range of methodologies including economic evaluation, large data analysis and use of qualitative methods in health economics. 
Mrs Ceila Ingham-Clark Medical Director for Clinical Effectiveness NHS England Mrs Clark is a Medical Director for Professional Leadership and Clinical Effectiveness; previous Trust Medical Director and general surgeon.
Dr David Kryl Director of Insight for Wessex AHSN  Wessex Academic Health Science Network (AHSN) Dr Kryl is responsible for the evaluation strategy of Wessex Academic Health Science Network, with expertise in implementation, research, evaluation, and impact assessment frameworks 
Mr Stuart Mealing Associate Director for Health Technology Assessment York Health Economics Consortium Ltd Mr Mealing has a range of experience in decision analytic modelling, statistical analysis of patient level data (from clinical trials to large real world evidence datasets), Preparation of health technology assessment submission dossiers
Mr Steve Morris CEO Creo Medical Mr Morris has over 15 years of experience managing complex projects and programmes in the Defence sector. He has led project teams for the Ministry of Defence, and delivering major projects for the Royal Navy and the British Army. Mr. Morris holds a BScEng and is a member of the IET and the Association for Project Management
Ms Stella O'Brien Public Committee Member    PPI  Representative  PPI  Representative
Mr Sebastian Orton Partner, Corporate Penningtons Manches LLP Mr Orton is a corporate finance lawyer with specific expertise in equity capital markets and raising finance for companies in the life sciences sector
Professor Najib Rahman Professor of Respiratory Medicine, Director Oxford Respiratory Trials Unit University of Oxford Najib has a broad range of expertise in clinical trials methodology, design, outcome and analysis. As well as expertise in, respiratory medicine including pleural disease, sleep apnoea, respiratory interventions, imaging, airways disease and lung cancer
Professor Amar Rangan Professor of Orthopaedic Surgery Universities of York and Oxford Professor Rangan is a specialist shoulder & elbow surgeon; Experienced in clinical effectiveness and translational research
Mr Simon Thorn Managing Director Acceleris Capital Limited Mr Thorn is experienced in evaluating the financial, corporate and commercial aspects of early stage healthcare propositions from a business viability and investability angle
Professor Wendy Tindale Director NIHR Devices for Dignity MIC Professor Tindale is involved in Test Beds and experienced in implementation of MedTech